Lv6
2240 积分 2021-06-25 加入
Directly and Indirectly Targeting the Glycine Modulatory Site to Modulate NMDA Receptor Function to Address Unmet Medical Needs of Patients With Schizophrenia
7小时前
已完结
Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities
8小时前
已完结
Preclinical characterization of AMPA receptor potentiator TAK‐137 as a therapeutic drug for schizophrenia
8小时前
已完结
Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia
8小时前
已关闭
Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia
9小时前
已完结
Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled Trial
9小时前
已完结
Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
9小时前
已完结
Advances in schizophrenia research and treatment: exploring neurotransmitter imbalances, genetics, and innovative therapies
10小时前
已完结
Schizophrenia: Disability, Clinical Insights, and Management
10小时前
已完结
Schizophrenia management: Systematic review of current medications and Phase-3 agents (2008–2024)
10小时前
已完结
皖公网安备34019202002308
